Precision BioLogic’s Chromogenic FIX Assay Gets FDA Clearance
Precision BioLogic announced FDA 510(k) clearance and the launch of its new CRYOcheck Chromogenic Factor IX assay in the U.S.
Read MorePosted by Andy Lundin | Jan 6, 2023 | Hematology & Serology |
Precision BioLogic announced FDA 510(k) clearance and the launch of its new CRYOcheck Chromogenic Factor IX assay in the U.S.
Read MorePosted by Andy Lundin | Dec 13, 2022 | Cancer |
A new clinical tool pinpoints which clonal hematopoiesis patients are at highest risk for cancer progression.
Read MorePosted by Andy Lundin | Dec 2, 2022 | Hematology & Serology, Point-of-Care |
HemoSonics has received 510(k) market clearance from the U.S. FDA for the Quantra Hemostasis System with QStatCartridge.
Read MorePosted by Andy Lundin | Nov 28, 2022 | Sexually Transmitted Diseases |
Chembio announced the submission to the FDA for a Clinical Laboratory Improvement Amendments waiver for the DPP HIV-Syphilis System.
Read MorePosted by Chris Wolski | Nov 28, 2022 | Flow Cytometry, Lab Automation |
The ongoing clinical laboratory labor shortage is putting a strain on the U.S. healthcare system, but automation can help clinical labs cope.
Read More